查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1842020

美国主动脉瓣置换装置市场：市场规模、份额、趋势分析（按产品、瓣叶材料、支架材料和最终用途划分）、细分市场预测（2025-2033 年）

U.S. Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report By Product, By Leaflet Material, By Frame Material, By End Use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国主动脉瓣置换装置市场摘要

2024 年美国主动脉瓣置换装置市场规模估计为 40.8 亿美元，预计到 2033 年将达到 93.5 亿美元，2025 年至 2033 年的复合年增长率为 9.4%。

主动脉瓣狭窄的盛行率不断上升（主要发生在老年人口中），以及外科手术和经导管治疗的良好临床效果，推动了这个市场的发展。

随着65岁及以上患者数量的不断增加，外科主动脉瓣置换术（SAV​​R）和经导管主动脉瓣置换术（TAVR）的需求持续成长。由于TAVR具有微创、恢復时间短等优点，因此更受广泛接受。根据西南医学中心网站上的报导报道，美国每年约进行10万例TAVR手术，截至2024年11月，该医学中心已完成超过1000例经导管主动脉瓣置换术（TAVR）。

技术创新仍然是该市场的关键驱动力，其重点在于提高器械的耐用性并改善微创手术的输送系统。製造商持续投资研发，以延长人工瓣膜的使用寿命，这对于可能更长时间佩戴人工瓣膜的年轻患者至关重要。

由于企业为获取技术优势或市场进入采取的策略性倡议，併购活动略有增加。 2024年7月，爱德华生命科学公司宣布一项约12亿美元的策略投资，用于收购Jena Valve Technologies和Endotronics，以扩展其结构性心臟病产品组合。收购Jena Valve Technologies将巩固爱德华在美国主动脉瓣膜置换器械行业的地位，并瞄准目前服务不足的瓣膜闭锁不全领域。继先前的投资后，收购Endotronics将使爱德华能够凭藉其获得FDA核准的Cordella感测器进军心臟衰竭治疗领域。这些策略性倡议旨在满足患者未被满足的需求，并支持公司的长期成长。

FDA要求进行广泛的临床试验和上市后监测，这可能会延迟产品上市，但能确保高安全标准。 2025年5月，FDA核准了爱德华生命科学公司的Sapien 3 Ultra Resilia TAVR瓣膜，用于治疗无症状性主动脉瓣狭窄（AS）。

目录

第一章 分析方法和范围

第二章执行摘要

第三章美国主动脉瓣置换装置市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场
    • 附随市场
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国主动脉瓣置换装置市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
    • 法律规范

第四章美国主动脉瓣置换装置市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 美国主动脉瓣置换装置市场：依产品分類的差异分析
  • 美国主动脉瓣置换装置市场规模及产品趋势分析（2021-2033）
  • 球囊扩张型
  • 自膨胀
  • 机械可膨胀
  • 主动脉瓣逆流

第五章美国主动脉瓣置换装置市场：依瓣叶材料分類的估算与趋势分析

  • 细分仪表板
  • 美国主动脉瓣置换装置市场：依瓣叶材料分類的差异分析
  • 美国主动脉瓣置换装置市场规模及趋势分析（依瓣叶材料划分）（2021-2033 年）
  • 牛心包
  • 猪心包

第六章：美国主动脉瓣置换装置市场：依框架材料分類的估算与趋势分析

  • 细分仪表板
  • 美国主动脉瓣置换装置市场：按框架材料分類的差异分析
  • 美国主动脉瓣置换装置市场规模及趋势分析（按框架材料划分）（2021-2033 年）
    • 钴铬
    • 镍钛合金
    • 其他的

第七章美国主动脉瓣置换装置市场：依最终用途分類的估算与趋势分析

  • 细分仪表板
  • 美国主动脉瓣置换装置市场：依最终用途分類的差异分析
  • 美国主动脉瓣置换装置市场规模及趋势分析（依最终用途划分）（2021-2033 年）
    • 住院设施
    • 门诊设施

第八章 竞争情势

  • 市场参与企业分类
  • 企业市场分析/堆图分析
  • 公司简介
    • Boston Scientific Corporation
    • Artivion, Inc
    • Edwards Lifesciences Corporation
    • LivaNova PLC
    • Medtronic
    • Abbott
Product Code: GVR-4-68040-755-9

U.S. Aortic Valve Replacement Devices Market Summary

The U.S. aortic valve replacement devices market size was estimated at USD 4.08 billion in 2024 and is projected to reach USD 9.35 billion by 2033, growing at a CAGR of 9.4% from 2025 to 2033. The market is primarily driven by the increasing prevalence of aortic stenosis in an aging population and favorable clinical outcomes from surgical and transcatheter approaches.

With a growing number of patients over age 65, demand for surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) continues to rise. Clinical outcomes have improved significantly over the past decade, with TAVR gaining wider acceptance due to its less invasive nature and reduced recovery times. As per the article on the Southwestern Medical Center website, approximately 100,000 TAVR procedures are performed annually in the U.S and as of November 2024, the medical centre had performed more than 1,000 transcatheter aortic valve replacement (TAVR) procedures.

Innovation remains a critical driving force within this market, with a strong focus on enhancing device durability and improving delivery systems for less invasive procedures. Manufacturers are continuously investing in research and development to extend the lifespan of prosthetic valves, which is crucial for younger patients who may live longer with their implanted devices.

Merger and acquisition is moderately high, driven by strategic efforts to gain technological advantages or market access. In July 2024, Edwards Lifesciences announced a strategic investment of around USD 1.2 billion to acquire JenaValve Technology and Endotronix, expanding its structural heart portfolio. Acquiring JenaValve Technology enhances Edward's position in the U.S. aortic valve replacement devices industry, targeting the underserved aortic regurgitation segment. The purchase of Endotronix, following an earlier investment, allows Edwards to enter heart failure management with its FDA-approved Cordella sensor. These strategic moves aim to address unmet patient needs and support long-term growth.

The FDA requires extensive clinical trials and post-market surveillance, which can delay product launches and ensure high safety standards. In May 2025, the FDA approved Edwards Lifesciences Sapien 3 Ultra Resilia TAVR valves for treating asymptomatic severe aortic stenosis (AS).

U.S. Aortic Valve Replacement Devices Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. aortic valve replacement devices market report based on product, leaflet material, frame material, and end use.

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Balloon-expandable
  • Self-expandable
  • Mechanically expandable
  • Aortic regurgitation
  • Leaflet Material Outlook (Revenue, USD Billion, 2021 - 2033)
  • Bovine pericardium
  • Porcine pericardium
  • Frame Material Outlook (Revenue, USD Billion, 2021 - 2033)
  • Cobalt-chromium
  • Nitinol
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Inpatient Facilities
  • Outpatient Facilities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Aortic Valve Replacement Devices Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Aortic Valve Replacement Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitution
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
    • 3.3.3. Regulatory Framework

Chapter 4. U.S. Aortic Valve Replacement Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Aortic Valve Replacement Devices Market: Product Movement Analysis
  • 4.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by product, 2021 to 2033 (USD Billion)
  • 4.4. Balloon-expandable
    • 4.4.1. Balloon-expandable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.5. Self-expandable
    • 4.5.1. Self-expandable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.6. Mechanically expandable
    • 4.6.1. Mechanically expandable Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 4.7. Aortic regurgitation
    • 4.7.1. Aortic regurgitation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. U.S. Aortic Valve Replacement Devices Market: Leaflet Material Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Aortic Valve Replacement Devices Market: Leaflet Material Movement Analysis
  • 5.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by leaflet material, 2021 to 2033 (USD Billion)
  • 5.4. Bovine pericardium
    • 5.4.1. Bovine Pericardium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 5.5. Porcine pericardium
    • 5.5.1. Porcine Pericardium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. U.S. Aortic Valve Replacement Devices Market: By Frame Material Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Aortic Valve Replacement Devices Market: By Frame Material Movement Analysis
  • 6.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by frame material, 2021 to 2033 (USD Billion)
    • 6.3.1. Cobalt-chromium
      • 6.3.1.1. Cobalt-chromium Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.3.2. Nitinol
      • 6.3.2.1. Nitinol Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.3.3. Others
      • 6.3.3.1. Other Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. U.S. Aortic Valve Replacement Devices Market: By End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Aortic Valve Replacement Devices Market: By End Use Movement Analysis
  • 7.3. U.S. Aortic Valve Replacement Devices Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Billion)
    • 7.3.1. Inpatient Facilities
      • 7.3.1.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.3.2. Outpatient Facilities
      • 7.3.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heap Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Boston Scientific Corporation
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Artivion, Inc
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Edwards Lifesciences Corporation
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. LivaNova PLC
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Medtronic
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Abbott
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 U.S. Aortic Valve Replacement Devices Market, by Product, 2021 - 2033 (USD Billion)
  • Table 3 U.S. Aortic Valve Replacement Devices Market, by Leaflet Material, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Aortic Valve Replacement Devices Market, by Frame Material, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Aortic Valve Replacement Devices Market, by End Use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Aortic Valve Replacement Devices Market revenue, 2021 - 2033 (USD Billion)
  • Fig. 10 U.S. Aortic Valve Replacement Devices Market snapshot
  • Fig. 11 U.S. Aortic Valve Replacement Devices Market driver impact
  • Fig. 12 U.S. Aortic Valve Replacement Devices Market Restraint Impact
  • Fig. 13 Aortic Valve Replacement Devices product key takeaways (USD Billion)
  • Fig. 14 U.S. Aortic Valve Replacement Devices Market: product movement analysis
  • Fig. 15 Balloon-expandable Market, 2021 - 2033 (USD Billion)
  • Fig. 16 Self-expandable Market, 2021 - 2033 (USD Billion)
  • Fig. 17 Mechanically expandable Market, 2021 - 2033 (USD Billion)
  • Fig. 18 Aortic Regurgitation Market, 2021 - 2033 (USD Billion)
  • Fig. 19 Aortic Valve Replacement Devices Leaflet Material Key Takeaways (USD Billion)
  • Fig. 20 U.S. Aortic Valve Replacement Devices Market: Leaflet Material Movement Analysis
  • Fig. 21 Bovine Pericardium Market, 2021 - 2033 (USD Billion)
  • Fig. 22 Porcine Pericardium Market, 2021 - 2033 (USD Billion)
  • Fig. 23 U.S. Aortic Valve Replacement Devices Market Frame Material key takeaways (USD Billion)
  • Fig. 24 U.S. Aortic Valve Replacement Devices Market: Frame Material movement analysis
  • Fig. 25 Cobalt-Chromium Market, 2021 - 2033 (USD Billion)
  • Fig. 26 Nitinol Market, 2021 - 2033 (USD Billion)
  • Fig. 27 Others Market, 2021 - 2033 (USD Billion)
  • Fig. 28 U.S. Aortic Valve Replacement Devices Market by End Use Key Takeaways (USD Billion)
  • Fig. 29 U.S. Aortic Valve Replacement Devices Market: by End Use Movement Analysis
  • Fig. 30 Outpatient Facilities Market, 2021 - 2033 (USD Billion)
  • Fig. 31 Inpatient Facilities Market, 2021 - 2033 (USD Billion)
  • Fig. 32 Market Participant Categorization